Retractable Technologies, Inc
Retractable Technologies Inc. designs and manufactures safety-engineered injection devices, including syringes and needles, for healthcare use. The company serves domestic and international customers from the United States and also sources some finished goods through manufacturing arrangements in China.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueInjection syringes used for vaccination and general medical administration, including domestic production.
Needles and related safety-engineered sharps products sold to healthcare customers.
EasyPoint® safety needle products used in healthcare settings and retail pharmacy channels.
Products sold to overseas customers, including some shipments sourced from China.
Products
Reported · share of revenue- Syringes65.1 %
- Easy Point Needles31.2 %
- Blood Collection Products3.6 %
- Other Products0.1 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
The company sells primarily into healthcare distribution channels, including general line distributors and retail pharmacy customers. It also serves domestic customers tied to vaccination programs and international buyers that purchase selected syringe and needle products. Demand can vary by flu season, vaccination activity, and distributor inventory levels.
Buy syringes and needles for resale into healthcare supply chains and manage inventory based on demand.
Buy EasyPoint® products for vaccination and flu-season use, where seasonal demand can be important.
Purchase syringes and related products for immunization campaigns and public health use.
Buy selected syringe and needle products, including discounted EasyPoint® sales in some markets.
Strategy
The company’s strategic focus is to expand domestic manufacturing capacity and reduce reliance on imported finished goods. It also seeks to manage product mix, seasonal demand, and distributor relationships while preserving liquidity through operations, investments, and other available sources of cash.
Reduces dependence on imported supply and supports tariff-sensitive products.
Syringes and EasyPoint® products can support better pricing and demand patterns.
Operations, tariffs, and capital spending require flexible funding sources.
Geography
Q3/2024Retractable Technologies is based in the United States, where it also manufactures a meaningful portion of its products. The company sells internationally as well, and some products are sourced from China or shipped directly from China to customers, creating exposure to trade policy and cross-border supply chains.
Risks
The business is exposed to tariff policy, supply-chain disruption, and the cost of shifting more production into the United States. It also faces demand volatility from vaccination trends, distributor inventory swings, and seasonal flu patterns, while accounting estimates for rebates and inventory write-offs can affect reported results.
Imported syringes, needles, and other products are exposed to high tariff rates.
Exposure: Products sourced from China
Customers may hold excess vaccination inventory, reducing reorder demand.
Exposure: Domestic syringe sales
Moving production domestically requires equipment, molds, and workforce ramp-up.
Exposure: U.S. manufacturing operations
Flu season and public acceptance of vaccinations drive volume variability.
Exposure: Syringes and EasyPoint® products
Distributor rebates and inventory-related write-offs depend on judgment and assumptions.
Exposure: Accounts payable and cost of sales
Accounting
Judgemental itemsManagement estimates future credits using distributor history, inventories, and redemption rates.
Impact: Can materially affect accounts payable and net income
Products nearing expiration may require write-downs or higher expense recognition.
Impact: Affects cost of manufactured product and gross margin
Unrealized gains and losses flow through earnings and can dominate period results.
Impact: Affects net income and operating cash flow reconciliation
Tariffs on imported products are included in product cost and affect period comparability.
Impact: Raises cost of sales and reduces reported margins
Similar listed companies
Publicly listed companies with a comparable business focus.
Work Medical Technology Group LTD
WOK · Surgical & Medical Instruments & Apparatus
WORK Medical Technology Group LTD is a medical device company with operating subsidiaries in China that develops and manufactures Class I and II medical devices and sells disposable medical products.
Reliability Inc
RLBY · Services-Help Supply Services
RELIABILITY INC is a U.S.-based services company in the help supply services industry, providing media services and related staffing or support services to clients across multiple sectors.
Teleflex Incorporated
TFX · Surgical & Medical Instruments & Apparatus
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
Tactile Systems Technology, Inc
TCMD · Surgical & Medical Instruments & Apparatus
Tactile Systems Technology is a U.S.-based medical technology company that develops and sells home-based devices for chronic disease management.
Harvard Apparatus Regenerative Technology, Inc.
HRGN · Surgical & Medical Instruments & Apparatus
Last updated: 29/04/2026